Insider Purchases: Inside the Buy
Tag: Stocks
Lululemon (LULU): 68% Off — Bargain or Value Trap? 🧘
Lululemon (LULU) has fallen sharply from its highs, but insider buying and international growth suggest opportunity. Is this a contrarian buy—or a value trap in disguise?
PODD Stock Analysis 2026: Is Insulet the Ultimate Growth Play or a Valuation Trap?
Insulet (PODD) just delivered 31% revenue growth and insiders are buying — yet the stock trades at 70x earnings. Is this premium medtech compounder a long-term winner or priced for perfection? Here’s the FUNanc1al breakdown.
POOL Stock Analysis 2026: Why Insiders & Buffett Are Diving In
Insiders are buying, Buffett is in, shorts are nervous—and POOL is 63% off its highs. A deep dive into the maintenance moat behind this backyard empire.
KKR: The Private Equity Giant Offering Public-Scale Prosperity
KKR is no longer just for billionaires in wood-paneled boardrooms. With insiders buying, earnings compounding, and shares still ~38% below highs, the private equity giant looks like public-scale opportunity.
Six Months Ago, a Director Bought Sweetgreen (SG) at Twice the Price It Trades Today — Should You Indulge?
Sweetgreen’s stock has been chopped in half, insiders are under water, and institutions somehow own more shares than exist. But with AI-powered “Infinite Kitchens,” loyal customers, and a cult brand, could this be the comeback salad of the year—or another case of tossed expectations?
Helen of Troy (HELE) — Insider Buys, CFOs Turned CEOs, and a Falling Knife You Might Want to Catch (Carefully)
The CEO and CFO of Helen of Troy just bought shares as the stock plunges 90%. Are we looking at a tragic tale, or a comeback for the ages? We dig into the numbers, leadership shuffle, and Wall Street signals—with humor and historical flair.
Largest Insider Stock Purchases Belonged in Biotech and Energy the Week of 9/18/23
Two verticals constituted the lion share of insider purchases last week. In biotech, Neumora Therapeutics (NMRS) saw Amgen (AMGN) and the CEO buying shares. Rayzebio (RYZB) and Ambrx Bio (AMAM) also saw large insider accumulation. In the energy field, Chargepoint Holding (CHPT), Highpeak Energy (HPK) (where both the CEO and the President bought), Enphase Energy (ENPH), CNX Resources (CNX), and Riley Exploration (REPX) also saw insiders acquire substantial amounts of shares. Outside the biotech and energy verticals, of note are insider purchases at Maplebear (Instacart) (CART), Asana (ASAN) (where the CEO has been buying shares for months), and Westrock Coffee (WEST). CHPT buyer Wil VanLoh founded Quantum Energy Partners in 1998 and serves as CEO of the firm and as Chairman...